Sodium butyrate inhibits the phosphorylation of the retinoblastoma gene product in mouse fibroblasts by a transcription-dependent mechanism

Journal of Cellular Physiology

Volumn 166, Issue 3, 1996, Pages 631-636

  Buquet Fagot, Christine ^a   Lallemand, François ^a   Charollais, Renée Hélène ^b   Mester, Jan ^a  

^a HÔPITAL SAINT ANTOINE   (France)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BUTYRIC ACID; CYCLIN DEPENDENT KINASE; DACTINOMYCIN; MITOGEN ACTIVATED PROTEIN KINASE; RETINOBLASTOMA PROTEIN;

ANIMAL CELL; ARTICLE; CELL CYCLE; FIBROBLAST; GENE EXPRESSION; GENETIC TRANSCRIPTION; MOUSE; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; TUMOR SUPPRESSOR GENE;

EID: 0029962964     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4652(199603)166:3<631::AID-JCP18>3.0.CO;2-9     Document Type: Article

References (35)

1. Auffray, C., and Rougeon, F. (1980) Purification of mouse immunoglobulin heavy chain messenger RNAs from total myeloma tumor RNA. Eur. J. Biochem., 260:303-314.
2. Bandara, R.L., and LaThangue, N.B. (1991) Adenovirus E1A prevents the retinoblastoma gene product from complexing with a cellular transcription factor. Nature, 352:249-251.
3. Brands, J.H.G.M., Maasen, J.A., van Hemert, F., Amons, R., and Moller, W. (1986) The primary structure of the a subunit of human elongation factor-1. Structural aspects of guanine-nucleotide-binding sites. Eur. J. Biochem., 155:167-171.
4. Brunet, A., Pagès, G., and Pouysségur, J. (1994) Constitutively active mutants of MAP kinase kinase (MEK1) induce growth factor-relaxation and oncogenicity when expressed in fibroblasts. Oncogene, 9:3379-3387.
5. Buchou, T., Charollais, R.H., Fagot, D., and Mester, J. (1989) Mitogenic activity of phorbol esters and insulin-like growth factor 1 in chemically transformed mouse fibroblasts BP-A31: Independent effects and differential sensitivity to 3-isobutyl-1-methyl xanthine. Exp. Cell Res., 182:129-143.
6. Buquet-Fagot, C., Fagot, D., and Mester, J. (1993) Cell cycle dependent regulation of cdc2 mRNA in mouse fibroblasts: Requirement of protein synthesis and of continued mitogenic stimulation. J. Cell. Physiol., 155:204-209.
7. Campisi, J., Gray, H.E., and Pardee, A.B. (1984) Cell-cycle control of c-myc but not c-ras expression is lost following chemical transformation. Cell, 36-241-247.
8. Charollais, R.H., Buquet, C., and Mester, J. (1990) Butyrate blocks the accumulation of cdc2 mRNA in late G1 but inhibits both the early and late G1 progression in chemically transformed mouse fibroblasts. J. Cell. Physiol., 145:46-52.
9. Chen, P.-L., Scully, P., Shew, J.-Y., Wang, J.W.J., and Lee, W.-H. (1989) Phosphorylation of the retinoblastoma gene product is modu-lated during the cell cycle and cellular differentiation. Cell, 58:1193-1198
10. DeCaprio, J.A., Ludlow, J.W., Figge, J., Shew, J.-Y., Huang, C.-M., Lee, W.-H., Marsilio, E., Paucha, E., and Livingston, D.M. (1988) SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene. Cell, 54:275-283.
11. deFazio, A., Chiew, Y.-E., Donoghue, C., Lee, C.S.L., and Sutherland, R.L. (1992) Effect of sodium butyrate on estrogen receptor and epidermal growth factor gene expression in human breast cancer cell lines. J. Biol. Chem., 267:18008-1812.
12. El Deiry, W.S., Tokino, T., Velculescu, V.E., Levy, D.B., Parsons, R., Trent, J.M., Lin, D., Mercer, W.E., Kinzler, K.W., and Vogelstein, B. (1993) Waf1, a potential mediator of p53 tumor suppression. Cell, 75:817-825.
13. Fagot, D., Buquet-Fagot, C., and Mester, J. (1993) Mitogenic signaling by prostaglandins in chemically transformed mouse fibroblasts: Comparison with phorbol esters and insulin. Endocrinology, 132:1729-1734.
14. Fagot, D., Buquet-Fagot, C., Lallemand, F., and Mester, J. (1994) Antiproliferative effects of sodium butyrate in adriamycin-sensitive and -resistant human cancer cell lines. Anti-Cancer Drugs, 5:548-556.
15. Frégeau, C.J., Helgason, C., and Bleakley, R.C. (1992) Two cytotoxic cell proteinase genes are differentially sensitive to sodium butyrate. Nucleic Acids Res., 20:3113-3119.
16. Gill, R.K., and Christakos, S. (1993) Identification of sequence elements in mouse calbindin-D28k gene that confer 1,25-dihydroxyvitamin D3 and butyrate-inducible responses. Proc. Natl. Acad. Sci. U.S.A., 90:45-50.
17. Glauber, G.J., Wandersee, N.J., Little, J.A., and Cinder, G.D. (1991) 5'-flanking sequences mediate butyrate stimulation of embryonic globin gene expression in adult erythroid cells. Mol. Cell. Biol., 11:4690-4697.
18. Guan, K.-L., Jenkins, W.C., Li, Y., Nichols, M.A., Wu, X., O'Keefe, C.L., Matera, A.G., and Xiong, Y. (1994) Growth suppression by p18, a p16 (INK4B/MTS2)-related CDK6 inhibitor. Genes Dev., 8:2939-2952.
19. Harlow, E., and Lane, D. (1988) Antibodies: A Laboratory Manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
20. Joensuu, T., and Mester, J. (1995) Inhibition of cell cycle progression by sodium butyrate in normal rat kidney fibroblasts is altered by expression of the adenovirus 5 early IA gene. Biosci. Rep., 74:291-300.
21. Kosaka, M., Nishina, Y., Takeda, M., Matsumoto, K., and Nishimune, Y. (1991) Reversible effects of sodium butyrate on the differentiation of F9 embryonal carcinoma cells. Exp. Cell Res., 192:46-51.
22. Kruh, J. (1982) Effects of sodium butyrate, a new pharmacological agent, on cells in culture. Mol. Cell. Biochem., 42:65-82.
23. K1p2, a cyclin-dependent kinase inhibitor with a unique domain structure and tissue distribution. Genes Dev., 9:609-619.
24. Ludlow, J.W., DeCaprio, J.A., Huang, C.-M., Lee, W.-H., Paucha, E., and Livingstone, D.M. (1989) SV40 large T antigen binds preferentially to an underphosphorylated member of the retinoblastoma susceptibility gene product family. Cell, 56.57-65.
25. Maniatis, T., Fritch, E.F., and Sambrook, J. (1982) Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
26. CIPI Cdk inhibitor family, is a candidate tumor suppressor gene. Genes Dev., 9:650-662.
27. Peter, M., and Herskowitz, I. (1994) Joining the complex: Cyclin-dependent kinase inhibitory proteins and the cell cycle. Cell, 79 181-184.
28. Prasad, K.N. (1980) Butyric acid: A small fatty acid with diverse biological functions. Life Sci., 27:1351-1358.
29. Schönthal, A., and Feramisco, J.R. (1993) Inhibition of histone H1 kinase expression, retinoblastoma protein phosphorylation, and cell proliferation by the phosphatase inhibitor okadais acid. Oncogene, 8:433-441.
30. Steinman, R.A., Hoffman, B., Iro, A., Guillouf, C., Liebermann, D., and El-Houseini, M.E. (1994) Induction of p21 (WAF1/CIP1) during differentiation. Oncogene, 9:3389-3396.
31. Weinberg, R.A. (1995) The retinoblastoma protein and cell cycle control. Cell, 81:323-330.
32. Yamada, K., Ohtsu, M., Sugano, M.N., and Kimura, G. (1992) Effect of butyrate on cell cycle progression and polyploidization of various types of mammalian cells. Biosci. Biotechnol. Biochem., 56-1261-1265.
33. Yeivin, A., Tang, D., and Taylor, M.W. (1992) Sodium butyrate selectively induces transcription of promoters adjacent to the MoMSV viral enhancer. Gene, 176:159-164.
34. Yen, A., and Varvayanis, S. (1995) DMSO, sodium butyrate, and TPA induce hypophosphorylation of Rb with HL-60 cell differentiation. In Vitro Cell. Dev. Biol., 31:164-167.
35. Zhang, H., Hannon, G.J., and Beach, D. (1994) p21-containing cyclin kinases exist in both active and inactive states. Genes Dev., 8:1750-1758.